Immunic (IMUX) Earnings Date, Estimates & Call Transcripts

$1.37
+0.04 (+3.01%)
(As of 05/3/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 8
Before Market Opens
Confirmed
Actual EPS
(Feb. 22)
-$0.48 Beat By $0.03
Consensus EPS
(Feb. 22)
-$0.51
Skip Charts & View Estimated and Actual Earnings Data

IMUX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IMUX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Immunic Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.36)($0.36)($0.36)
Q2 20241($0.26)($0.26)($0.26)
Q3 20241($0.28)($0.28)($0.28)
Q4 20241($0.27)($0.27)($0.27)
FY 20244($1.17)($1.17)($1.17)

IMUX Earnings Date and Information

Immunic last issued its quarterly earnings data on February 22nd, 2024. The reported ($0.48) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.51) by $0.03. Immunic has generated ($2.11) earnings per share over the last year (($2.11) diluted earnings per share). Earnings for Immunic are expected to remain at ($0.99) per share in the coming year. Immunic has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. Immunic will be holding an earnings conference call on Wednesday, May 8th at 8:00 AM Eastern. Interested parties can register for or listen to the call..

Immunic Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Confirmed)
-------  
2/22/2024Q4 2023($0.51)($0.48)+$0.03($0.48)--
11/14/2023Q3 2023($0.55)($0.51)+$0.04($0.51)--
8/3/2023Q2 2023($0.52)($0.54)($0.02)($0.54)--
5/11/2023Q1 2023($0.54)($0.58)($0.04)($0.58)--
2/23/2023Q4 2022($0.82)($1.63)($0.81)($1.63)--
11/3/2022Q3 2022($0.64)($0.69)($0.05)($0.69)--
8/4/2022Q2 2022($0.68)($0.72)($0.04)($0.72)--
5/10/2022Q1 2022($0.80)($0.74)+$0.06($0.74)--
2/24/2022Q4 2021($0.73)($0.81)($0.08)($0.81)--    
11/4/2021Q3 2021($0.81)($0.76)+$0.05($0.76)--  
8/6/2021Q2 2021($0.68)($0.82)($0.14)($0.82)--
5/6/2021Q1 2021($0.71)($1.63)($0.92)($1.63)--  

Immunic Earnings - Frequently Asked Questions

When is Immunic's earnings date?

Immunic has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on IMUX's earnings history.

Did Immunic beat their earnings estimates last quarter?

In the previous quarter, Immunic (NASDAQ:IMUX) reported ($0.48) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.51) by $0.03. Learn more on analysts' earnings estimate vs. IMUX's actual earnings.

How much profit does Immunic generate each year?

Immunic (NASDAQ:IMUX) has a recorded net income of -$93.61 million. IMUX has generated -$2.11 earnings per share over the last four quarters.

What is Immunic's EPS forecast for next year?

Immunic's earnings are expected to stay at ($0.99) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:IMUX) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners